Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression
about
Probing Functional Heteromeric Chemokine Protein-Protein Interactions through Conformation-Assisted Oxime LigationTumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysmRGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling.Arrest of progression of pre-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by low level laser phototherapy.Performance comparison of ultrasound-based methods to assess aortic diameter and stiffness in normal and aneurysmal miceHypoperfusion of the Adventitial Vasa Vasorum Develops an Abdominal Aortic Aneurysm.Metformin treatment status and abdominal aortic aneurysm disease progression.MKEY, a Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, Protects Against Stroke in Mice.Targeting CCL5 in inflammation.Role of the renin-angiotensin system on abdominal aortic aneurysms.Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies.New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.Monocytes and macrophages in abdominal aortic aneurysm.Activation of Endocannabinoid System Is Associated with Persistent Inflammation in Human Aortic Aneurysm.A crosstalk triggered by hypoxia and maintained by MCP-1/miR-98/IL-6/p38 regulatory loop between human aortic smooth muscle cells and macrophages leads to aortic smooth muscle cells apoptosis via Stat1 activationInhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysmsPro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.Transcriptome sequencing revealed candidate genes relevant to mesenchymal stem cells' role in aortic dissection patients.Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.Low molecular weight fucoidan attenuates experimental abdominal aortic aneurysm through interfering the leukocyte-endothelial cells interaction.Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis.
P2860
Q28818194-7855B978-CB84-4BF1-A8E0-56FDC65BD76BQ35026182-DA86177F-F5E7-48F0-94E0-AB3A3755A94BQ35121871-3BC5EDEA-5C03-403F-ADAD-C4768D82C21BQ35218126-6C41A093-BD10-44A2-9B9A-EB14CE5FC4CCQ35437077-BAA4BF48-A84C-4B58-909D-B5B66CB949B0Q35645966-1F52CE6B-3EF5-479A-AA43-D6AD34B95F2FQ35755854-DCC62750-B898-4A86-A832-8F15F3F93B11Q37047861-174A6CDF-84FF-4C46-A076-817E161D2910Q37364433-53BAF987-7E11-47C5-9AB3-B71485BBA831Q38148785-C60D3FE6-A317-479E-B573-F360081B3F62Q38153772-6F439626-CFB0-4063-A95E-BD4CDED3C73AQ38233795-F86FFA6B-615F-4724-A7F8-ADB19114F4D1Q38815332-4D9A535C-717C-4300-BBB2-60856558B347Q38824336-34E55ECE-9912-4647-BCFE-86ED30AB4815Q39239967-0E7F90B0-D2D8-4BA0-9E98-6B24D5638F24Q40353543-75103AD5-3C52-43E8-937B-52E3015FFB65Q40867240-81AB0B2A-0C15-46C2-B9FF-FED7881011BEQ41994097-6D2A54FF-BBF2-4235-A426-E7F886B9A237Q42378982-3B05EC2D-CCB6-47AA-91DB-491467A41B59Q46296444-ADDFFEEB-0731-4CB9-A41A-0AF2DF4A89E8Q47292596-8713B03C-5ECE-4EBF-BA6D-CE4658B7C4B1Q47634824-6F1E4418-3F55-42B2-9944-B96CC14E8222Q47760731-1C826E18-4AE5-4D69-95F4-9255A28FD5DDQ50239051-19251A66-B1B8-48C2-B0DD-44C3DDD8082AQ55221204-C97C9473-4D6E-4F96-AEEB-34531558E5B1Q55640686-681D0FE7-3D55-46D4-B93F-E6BBDA1695A5
P2860
Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@ast
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@en
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@nl
type
label
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@ast
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@en
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@nl
prefLabel
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@ast
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@en
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@nl
P2093
P2860
P1476
Peptide inhibitor of CXCL4-CCL ...... ysm initiation and progression
@en
P2093
Court R Turner
Haojun Xuan
Hiroki Tanaka
Joshua R Schultz
Keith J Glover
Naoki Fujimura
Ronald L Dalman
Xiaolei Hu
P2860
P304
P356
10.1161/ATVBAHA.112.300329
P407
P577
2013-01-03T00:00:00Z